Benjamin Ungar, MD, FAAD
SESSIONS
F011 DataDerm: The First Decade and Goals for the Next
Mar 8, 2024
•
9:00 AM - 11:00 AM
•
Room 6F
S040 Inflammatory Skin Diseases: The Translational Revolution
Mar 9, 2024
•
1:00 PM - 4:00 PM
•
Room 6A
DISCLOSURES
Arcutis Biotherapeutics – Advisory Board(Honoraria); Bristol-Myers Squibb – Advisory Board(Honoraria); Castle Biosciences – Advisory Board(Honoraria); Fresenius Kabi – Advisory Board(Honoraria); Galderma – Advisory Board(Honoraria); Incyte Corporation – Investigator(Grants/Research Funding); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Primus Pharmaceuticals – Advisory Board(Honoraria); RAPT Therapeutics – Investigator(Grants/Research Funding); Sanofi – Advisory Board(Honoraria); Target-Derm – Advisory Board(Honoraria); UCB – Advisory Board(Honoraria);